title: The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.
abstract: Deletion of the chemokine receptor CXCR2 prevents the recruitment of neutrophils into tissues and subsequent development of experimental Lyme arthritis. Following footpad inoculation of Borrelia burgdorferi, the agent of Lyme disease, expression of the CXCR2 ligand KC (CXCL1) is highly upregulated in the joints of arthritis-susceptible mice and is likely to play an important role in the recruitment of neutrophils to the site of infection. To test this hypothesis, we infected C3H KC(-/-) mice with B. burgdorferi and followed the development of arthritis and carditis. Ankle swelling was significantly attenuated during the peak of arthritis in the KC(-/-) mice. Arthritis severity scores were significantly lower in the KC(-/-) mice on days 11 and 21 postinfection, with fewer neutrophils present in the inflammatory lesions. Cardiac lesions were also significantly decreased in KC(-/-) mice at day 21 postinfection. There were, however, no differences between C3H wild-type and KC(-/-) mice in spirochete clearance from tissues. Two other CXCR2 ligands, LIX (CXCL5) and MIP-2 (CXCL2), were not increased to compensate for the loss of KC, and the production of several innate cytokines was unaltered. These results demonstrate that KC plays a critical nonredundant role in the development of experimental Lyme arthritis and carditis via CXCR2-mediated recruitment of neutrophils into the site of infection.
authors.affiliation: Department of Veterinary Pathobiology, University of Missouri, Columbia, MO 65211, USA.
authors.forename: Anna M
authors.initials: AM
authors.lastname: Ritzman
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Hughes-Hanks
authors.forename: Victoria A
authors.initials: VA
authors.lastname: Blaho
authors.forename: Laura E
authors.initials: LE
authors.lastname: Wax
authors.forename: William J
authors.initials: WJ
authors.lastname: Mitchell
authors.forename: Charles R
authors.initials: CR
authors.lastname: Brown
mesh_terms: D000818:Animals; D001169:Arthritis, Experimental / Q000276:immunology / Q000382:microbiology / Q000473:pathology*; D025065:Borrelia burgdorferi / Q000276:immunology / Q000472:pathogenicity*; D054360:Chemokine CXCL1 / Q000378:metabolism*; D004195:Disease Models, Animal; D005260:Female; D008024:Ligands; D008193:Lyme Disease / Q000276:immunology / Q000382:microbiology / Q000473:pathology*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D018345:Mice, Knockout; D009205:Myocarditis / Q000276:immunology / Q000382:microbiology / Q000473:pathology*; D020556:Neutrophil Infiltration / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology; D023063:Receptors, Interleukin-8B / Q000378:metabolism*; D012720:Severity of Illness Index; D015398:Signal Transduction
chemical_list: D054360:Chemokine CXCL1; D008024:Ligands; D023063:Receptors, Interleukin-8B
references.citation: Pharmacol Ther. 2006 Oct;112(1):139-49
references.pmid: 16720046
references.citation: Nat Immunol. 2008 Sep;9(9):988-98
references.pmid: 18711436
references.citation: Infect Immun. 1998 May;66(5):2065-71
references.pmid: 9573090
references.citation: J Immunol. 2001 Aug 1;167(3):1601-8
references.pmid: 11466382
references.citation: Infect Immun. 2003 Aug;71(8):4711-6
references.pmid: 12874352
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5954-9
references.pmid: 19289819
references.citation: J Clin Microbiol. 1999 Apr;37(4):987-92
references.pmid: 10074514
references.citation: Adv Immunol. 1999;73:369-509
references.pmid: 10399011
references.citation: J Immunol. 1995 Oct 1;155(7):3660-6
references.pmid: 7561066
references.citation: Arthritis Res Ther. 2008;10(5):224
references.pmid: 18947376
references.citation: Arthritis Res Ther. 2007;9(4):R65
references.pmid: 17612407
references.citation: J Infect Dis. 1995 Feb;171(2):362-70
references.pmid: 7844373
references.citation: Arthritis Rheum. 2010 Jul;62(7):1921-32
references.pmid: 20506316
references.citation: Arthritis Res. 2001;3(1):65-71
references.pmid: 11178128
references.citation: Arthritis Rheum. 2008 Aug;58(8):2329-37
references.pmid: 18668539
references.citation: Am J Pathol. 1984 Oct;117(1):26-9
references.pmid: 6333185
references.citation: J Leukoc Biol. 2010 Jun;87(6):965-75
references.pmid: 20089669
references.citation: J Infect Dis. 1990 Jul;162(1):133-8
references.pmid: 2141344
references.citation: Arthritis Rheum. 2008 Jul;58(7):1931-9
references.pmid: 18576354
references.citation: Biochem Biophys Res Commun. 2010 Jan 1;391(1):1080-6
references.pmid: 20004647
references.citation: J Infect Dis. 1988 Apr;157(4):842-6
references.pmid: 3258003
references.citation: J Infect Dis. 1999 Mar;179(3):734-7
references.pmid: 9952389
references.citation: Shock. 2003 Apr;19(4):358-65
references.pmid: 12688548
references.citation: J Leukoc Biol. 1998 Oct;64(4):494-502
references.pmid: 9766630
references.citation: J Interferon Cytokine Res. 2006 Jun;26(6):390-9
references.pmid: 16734559
references.citation: J Leukoc Biol. 2004 Apr;75(4):641-8
references.pmid: 14704366
references.citation: J Immunol. 2007 Apr 15;178(8):5109-15
references.pmid: 17404293
references.citation: J Immunol. 1999 Jun 15;162(12):7492-500
references.pmid: 10358204
references.citation: Infect Immun. 2005 Nov;73(11):7637-43
references.pmid: 16239568
references.citation: Am J Trop Med Hyg. 1992 Aug;47(2):249-58
references.pmid: 1503192
references.citation: Infect Immun. 1992 Sep;60(9):3630-4
references.pmid: 1500171
references.citation: Lab Invest. 2002 Oct;82(10):1297-304
references.pmid: 12379764
references.citation: J Clin Invest. 1996 Feb 15;97(4):1028-34
references.pmid: 8613525
references.citation: J Immunol. 2002 Apr 1;168(7):3586-94
references.pmid: 11907123
references.citation: Infect Immun. 2008 Dec;76(12):5500-7
references.pmid: 18824530
references.citation: Inflammation. 1984 Jun;8 Suppl:S3-14
references.pmid: 6090313
references.citation: Blood. 2009 Nov 19;114(21):4613-23
references.pmid: 19696199
references.citation: J Infect Dis. 2002 Jun 15;185(12):1773-9
references.pmid: 12085324
references.citation: J Clin Microbiol. 1999 Jun;37(6):1958-63
references.pmid: 10325354
references.citation: Clin Exp Immunol. 2002 Apr;128(1):44-51
references.pmid: 11982589
references.citation: Immunology. 2009 Jan;126(1):55-62
references.pmid: 18557953
references.citation: Br J Pharmacol. 2008 Mar;153(5):992-1002
references.pmid: 17891165
references.citation: J Leukoc Biol. 1998 Mar;63(3):359-63
references.pmid: 9500524
references.citation: Infect Immun. 2007 Feb;75(2):613-20
references.pmid: 17101663
references.citation: Clin Exp Immunol. 1997 Feb;107(2):248-53
references.pmid: 9030860
references.citation: J Clin Invest. 1994 Sep;94(3):1012-8
references.pmid: 8083342
references.citation: Infect Immun. 1998 Jan;66(1):161-8
references.pmid: 9423853
references.citation: Arthritis Rheum. 2005 Mar;52(3):710-21
references.pmid: 15751074
references.citation: Arthritis Rheum. 2001 Jun;44(6):1428-37
references.pmid: 11407705
references.citation: Ann Intern Med. 1980 Jul;93(1):8-16
references.pmid: 6967274
references.citation: J Immunol. 1997 May 15;158(10):4838-45
references.pmid: 9144499
references.citation: J Exp Med. 2007 Nov 26;204(12):2797-802
references.pmid: 17998392
references.citation: Arthritis Rheum. 2008 Jul;58(7):2030-40
references.pmid: 18576322
references.citation: Rheum Dis Clin North Am. 1995 Aug;21(3):691-714
references.pmid: 8619095
references.citation: Blood. 2008 Dec 15;112(13):5193-201
references.pmid: 18824600
references.citation: J Immunol. 2003 Jul 15;171(2):893-901
references.pmid: 12847259